Perez v. Bath & Body Works, LLC

District Court, N.D. California·Decided July 14, 2022·No. 5:21-cv-05606·Unknown

Opinion

CARMEN PEREZ, et al., Case No. 21-cv-05606-BLF

Plaintiffs, ORDER GRANTING IN PART AND v. DENYING IN PART MOTION TO DISMISS FIRST AMENDED BATH & BODY WORKS, LLC, et al., COMPLAINT Defendants. [Re: ECF No. 57]

In this case, Plaintiff Carmen Perez1 challenges representations made on a series of products sold by Defendants Bath & Body Works, LLC and Bath & Body Works, Inc. (“BBW”). Perez claims that BBW falsely claims that hyaluronic acid, an ingredient in those products, “attracts and retains up to 1,000x its weight in water to make skin look smoother and more supple.” Perez also says that BBW falsely claims that the products are “clinically tested to instantly lock in moisture,” that its “fast-absorbing formula immediately hydrates,” and that “hyaluronic acid is a water loving molecule.” She brings three common law claims and three California consumer protection claims and seeks to represent a California class of consumers who purchased the products after July 21, 2017. Now before the Court is BBW’s wide-ranging motion to dismiss under Rules 12(b)(1), 12(b)(2), 12(b)(6), and 12(f). ECF No. 57 (“MTD”); see also ECF No. 67 (“Reply”). Perez opposes the motion. ECF No. 66 (“Opp.”). The Court held a hearing on the motion on June 30, 2022. ECF No. 76. For the following reasons, the Court GRANTS IN PART and DENIES IN 1 The Court separately granted Defendants’ motion to compel arbitration as to claims brought by PART the motion to dismiss. As alleged in the First Amended Complaint, Defendant Bath & Body Works, LLC markets products including skin creams, lotions, scrubs, shampoos, conditioners, scents, and body wash to consumers who visit BBW’s stores or website. ECF No. 47 (“FAC”) ¶ 17. Among those products is a line called “WATER” / “HYDRATING”, which includes several products that use hyaluronic acid: • BBW Hyaluronic Acid Hydrating Body Cream (in varying scents); • BBW Hyaluronic Acid Hydrating Hand Cream (in varying scents); • BBW Hyaluronic Acid Hydrating Body Wash; • BBW Hyaluronic Acid Hydrating Body Gel Lotion; and • BBW Hyaluronic Acid Mineral Body Polish. Id. ¶ 20 (the “Products”). Perez alleges that BBW makes several false claims on the Products to “trick consumers into believing that the [Products] contain unique moisturizing properties.” FAC ¶ 21. Perez provides the example of the Hyaluronic Acid Hydrating Body Cream. Id. ¶¶ 22–25. The back of the tube of that product allegedly contains the following representations: • “attracts and retains up to 1,000x its weight in water” (Claim 1); • “instantly replenish moisture for smooth, hydrated skin” (Claim 2); • “make skin look smoother and more supple” (Claim 3); • “clinically tested to instantly lock in moisture” (Claim 4); • “fast-absorbing formula immediately hydrates” (Claim 5); and • “hyaluronic acid is a water loving molecule” (Claim 6). Id. ¶¶ 22, 24, 47, 53 (collectively, the “Claims”). Perez alleges that in-store personnel were instructed to make these claims and that BBW’s website contains similar representations. Id. ¶¶ 26–27. These claims are materially similar across the Products. Id. ¶ 29. Perez alleges that these representations are false. The hyaluronic acid in the product is, for 41. Scientific literature shows that hyaluronic acid binds only “a small amount of water,” Perez says. Id. ¶¶ 36–38. Perez alleges that BBW knows these representations are false, but made them anyway to take advantage of a growing market for beauty and skincare, particularly for hyaluronic acid products. Id. ¶¶ 42–45. In approximately February or March 2019, Plaintiff Carmen Perez visited a BBW store in Milpitas, California and purchased the Hyaluronic Acid Hydrating Body Cream. FAC ¶ 47. Based on the representations made on the product and repeated by a store employee, Perez believed the product was capable of moisturizing and hydrating her skin. Id. ¶¶ 47–48. Perez did not observe any improvement on her skin after use. Id. ¶ 49. This lawsuit was field on July 21, 2021, see ECF No. 1, and Perez filed the operative First Amended Complaint on January 10, 2022, see FAC. The First Amended Complaint asserts claims for violation of the Consumer Legal Remedies Act (“CLRA”), Cal. Civ. Code § 1750 et seq., FAC ¶¶ 71–81; violation of the False Advertising Law (“FAL”), Cal. Bus. & Prof. Code § 17500 et seq., FAC ¶¶ 82–93; fraud, deceit, and/or misrepresentation, id. ¶¶ 94–104; negligent misrepresentation, id. ¶¶ 105–112; violation of the Unfair Competition Law, Cal. Bus. & Prof. Code § 17200 et seq., FAC ¶¶ 113–123; and a quasi-contract claim for restitution, id. ¶¶ 124–128. Perez seeks to represent a class of all persons who purchased any of the Products from BBW in California from July 21, 2017 to the present. Id. ¶¶ 59–70. As an initial matter, Perez asks this Court to take judicial notice “of the proceedings” in Miller v. Peter Thomas Roth, LLC, No. 19-cv-698-WHA (N.D. Cal.) (“PTR”), a case involving claims regarding hyaluronic acid pending before another judge in this district. See Opp. at 7–8. Perez asks for judicial notice “of the entirety of the PTR proceeding,” including orders and evidence submitted in that case. Id. BBW opposes the “blanket request.” Reply at 2–3. Judicial notice of the entire PTR case is inappropriate and unwarranted. The Ninth Circuit (albeit in an unpublished opinion) has indicated disapproval of nonspecific requests for judicial notice like the one made here. See Assurance Co. of Am. v. Nat’l Fire & Marine Ins. Co., 595 F. dockets” made it “impossible for the court to glean from [the] request the facts [the party] wanted [the court] to notice”). The Court feels similarly: without further specificity, the Court cannot tell what information Perez wants this Court to notice, and the Court will not wade through hundreds of docket entries by itself. Furthermore, the categories of materials Perez seeks to have noticed (“evidence” regarding hyaluronic acid’s inability to retain moisture and an order on a motion for summary judgment) are not instructive on this motion to dismiss claims brought against a product not challenged in PTR. The request for judicial notice is accordingly DENIED. III. MOTION TO STRIKE – RULE 12(F) Rule 12(f) permits a court to “strike from a pleading an insufficient defense or any redundant, immaterial, impertinent, or scandalous matter.” Fed. R. Civ. P. 12(f). Motions to strike are “generally viewed with disfavor, and will usually be denied unless the allegations in the pleading have no possible relation to the controversy, and may cause prejudice to one of the parties.” Sliger v. Prospect Mortg., LLC, 789 F. Supp. 2d 1212, 1216 (E.D. Cal. 2012) (citations omitted); see also United States v. Wang, 404 F. Supp. 2d 1155, 1156 (N.D. Cal. 1991) (“[M]otions to strike should not be granted unless it is clear that the matter to be stricken could have no possible bearing on the subject matter of the litigation.”). BBW argues that references to the statement that the Products “instantly replenish moisture for smooth, hydrated skin” should be stricken from paragraphs 22, 47, 53, and 84 of the First Amended Complaint because that statement does not appear anywhere any hyaluronic acid product marketed or sold by BBW. MTD at 3–4. Perez does not oppose the request, saying she inadvertently failed to remove references to that statement. Opp. at 24. Because Perez does not oppose the request, and the

Free access — add to your briefcase to read the full text and ask questions with AI

Perez v. Bath & Body Works, LLC, (N.D. Cal. 2022).

Perez v. Bath & Body Works, LLC (Perez v. Bath & Body Works, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Williams v. Norris
25 U.S. 117 (Supreme Court, 1827)
International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Reese v. BP Exploration (Alaska) Inc.
643 F.3d 681 (Ninth Circuit, 2011)
Conservation Force v. Salazar
646 F.3d 1240 (Ninth Circuit, 2011)
Vess v. Ciba-Geigy Corp. USA
317 F.3d 1097 (Ninth Circuit, 2003)
Newcal Industries, Inc. v. IKON Office Solution
513 F.3d 1038 (Ninth Circuit, 2008)
In Re Gilead Sciences Securities Litigation
536 F.3d 1049 (Ninth Circuit, 2008)
Sliger v. Prospect Mortgage, LLC
789 F. Supp. 2d 1212 (E.D. California, 2011)
Apollo Capital Fund, LLC v. Roth Capital Partners, LLC
70 Cal. Rptr. 3d 199 (California Court of Appeal, 2007)
National Council Against Health Fraud, Inc. v. King Bio Pharmaceuticals, Inc.
133 Cal. Rptr. 2d 207 (California Court of Appeal, 2003)
United States v. Wang
404 F. Supp. 2d 1155 (N.D. California, 2005)
Walden v. Fiore
134 S. Ct. 1115 (Supreme Court, 2014)
Skye Astiana v. the Hain Celestial Group
783 F.3d 753 (Ninth Circuit, 2015)
Loredana Ranza v. Nike, Inc.
793 F.3d 1059 (Ninth Circuit, 2015)